The ASCO Annual Meeting is being held June 2 to 6. Several notable studies will be presented today. Topics include radiation therapy in rectal cancer, osimertinib for lung cancer, vorasidenib for grade 2 glioma, nivolumab for Hodgkin lymphoma, and mirvetuximab soravtansine for ovarian cancer. Read More >>
colorectal cancer
June 4, 2023 · ASCO Staff
November 10, 2022 · Brielle Gregory Collins, ASCO staff
Drs. David Ilson, Sumanta (Monty) Pal, and Tian Zhang discuss new research presented at the 2022 ESMO Congress, including studies about treating liver, colorectal, stomach, kidney, bladder, and prostate cancers. Read More >>
June 5, 2022 · Leslie Fannon Zhang, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma. Read More >>
June 4, 2022 · Brielle Gregory Collins, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer. Read More >>
May 24, 2022 · ASCO Staff
At-home DNA tests have become increasingly popular in recent years. But are they actually helpful for detecting cancer risk? In this post, learn about at-home DNA tests for cancer risk and why it’s always best to get genetic screening done through your health care provider. Read More >>